Literature DB >> 2934473

Leu-1+ (CD5+) B cells. A major lymphoid subpopulation in human fetal spleen: phenotypic and functional studies.

J H Antin, S G Emerson, P Martin, N Gadol, K A Ault.   

Abstract

Examination of the cell surface phenotype of fetal splenic lymphocytes demonstrated a major, novel subpopulation of B cells that co-express Leu-1 (CD5) in addition to B cell differentiation antigens (Leu-1+ B cells). These cells are similar to some conventional B cells in that they express HLA-DR, Leu-12, and B1, as well as both immunoglobulin (Ig) M and IgD. They comprise 40 to 60% of total splenic B cells in the fetus but are infrequent in fetal liver and adult spleen. Fetal Leu-1+ B cells do not respond to pokeweed mitogen with either proliferation or Ig secretion, and in contrast to the murine counterpart, Ly-1 B cells, they do not constitutively produce Ig. Leu-1+ B cells were incapable of augmenting Ig production of Leu-1- B cells when suboptimal numbers of T cells were present; however, they did require the presence of T cells to secrete antibody. They do not cap either the CD5 protein or surface Ig. These cells are a unique subpopulation of fetal splenic B cells that do not function as conventional B cells. Their role in the humoral immune response is unknown. They may represent the normal stage of B cell development, which is reflected in the phenotype of B cell CLL cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2934473

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  53 in total

1.  Identification and analysis of a novel human surface CD5- B lymphocyte subset producing natural antibodies.

Authors:  M T Kasaian; H Ikematsu; P Casali
Journal:  J Immunol       Date:  1992-05-01       Impact factor: 5.422

2.  Analysis of lymphocyte phenotypes in cord blood from early gestation fetuses.

Authors:  M Peakman; A G Buggins; K H Nicolaides; D M Layton; D Vergani
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

3.  CD5+ B cells are decreased in peripheral blood of patients with Crohn's disease.

Authors:  G A Neil; R W Summers; B A Cheyne; C Capenter; W L Huang; G S Kansas; T J Waldschmidt
Journal:  Dig Dis Sci       Date:  1992-09       Impact factor: 3.199

Review 4.  B-1 B cell development in the fetus and adult.

Authors:  Encarnacion Montecino-Rodriguez; Kenneth Dorshkind
Journal:  Immunity       Date:  2012-01-27       Impact factor: 31.745

Review 5.  Immune responses that adapt the intestinal mucosa to commensal intestinal bacteria.

Authors:  Andrew J Macpherson; Markus B Geuking; Kathy D McCoy
Journal:  Immunology       Date:  2005-06       Impact factor: 7.397

Review 6.  Immune deficiencies in chronic lymphocytic leukemia and multiple myeloma.

Authors:  A Winkelstein; P S Jordan
Journal:  Clin Rev Allergy       Date:  1992 Spring-Summer

7.  Effect of gold therapy on CD5+ B-cells and TCR gamma delta+ T-cells in patients with rheumatoid arthritis.

Authors:  J Hassan; C Feighery; B Bresnihan; A Whelan
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

8.  Relationship of the CD5 B cell to human tonsillar lymphocytes that express autoantibody-associated cross-reactive idiotypes.

Authors:  T J Kipps; S F Duffy
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

9.  Loss of a chromosomal region with synteny to human 13q14 occurs in mouse chronic lymphocytic leukemia that originates from early-generated B-1 B cells.

Authors:  K Hayakawa; A M Formica; M J Colombo; S A Shinton; J Brill-Dashoff; H C Morse Iii; Y-S Li; R R Hardy
Journal:  Leukemia       Date:  2016-03-08       Impact factor: 11.528

10.  Comparison of protein synthesis profiles in chronic lymphocytic leukaemia cells and B-lymphocytes from peripheral blood, cord blood and tonsil.

Authors:  F K Saunders; J Lawry; D A Winfield; J R Goepel; B W Hancock; R M Sharrard; M H Goyns
Journal:  Experientia       Date:  1994-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.